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Abstract
Background: 3D transesophageal echocardiography (TEE) is superior to 2D TEE in quantitative anatomic evaluation
of the mitral valve (MV) but it shows limitations regarding automatic quantification. Here, we tested the inter-/intra-observer
reproducibility of a novel full-automated software in the evaluation of MV anatomy compared to manual 3D
assessment.
Methods: Thirty-six out of 61 screened patients referred to our Cardiac Imaging Unit for TEE were retrospectively
included. 3D TEE analysis was performed both manually and with the automated software by two independent
operators. Mitral annular area, intercommissural distance, anterior leaflet length and posterior leaflet length were assessed.
Results: A significant correlation between both methods was found for all variables: intercommissural diameter (r = 0.
84, p < 0.01), mitral annular area (r = 0.94, p > 0, 01), anterior leaflet length (r = 0.83, p < 0.01) and posterior leaflet length
(r = 0.67, p < 0.01). Interobserver variability assessed by the intraclass correlation coefficient was superior for the
automatic software: intercommisural distance 0.997 vs. 0.76; mitral annular area 0.957 vs. 0.858; anterior leaflet length 0.
963 vs. 0.734 and posterior leaflet length 0.936 vs. 0.838. Intraobserver variability was good for both methods with a
better level of agreement with the automatic software.
Conclusions: The novel 3D automated software is reproducible in MV anatomy assessment. The incorporation of this
new tool in clinical MV assessment may improve patient selection and outcomes for MV interventions as well as
patient diagnosis and prognosis stratification. Yet, high-quality 3D images are indispensable.
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Background
The prevalence of severe valvular diseases increases with
age [1] thus representing an important public-health
problem. In Europe, mitral regurgitation is the second
most frequent valve disease requiring surgery [2]. Non-
invasive mitral valve (MV) anatomical and functional
evaluation is essential to define patient’s management.
Despite the increasing number and availability of alterna-
tive imaging modalities, echocardiography remains the
cornerstone in the assessment of MV morphology and
physiology [3].
Over the last 5 decades, Echocardiography has evolved
from mono-dimensional and two-dimensional (2D) im-
aging to sophisticated 3-dimensional (3D) techniques,
introducing a new era for cardiovascular imaging [4]. 2D
echocardiographic transesophageal approach increases
diagnostic accuracy; however, the complex anatomy of
the so-called MV apparatus remains in many cases still a
challenge. 3D transesophageal echocardiography (TEE) has
proved to overcome some of the 2D echocardiographic
limitations in MV assessment, providing more accurate
geometric information of the MV than 2D TEE [5, 6]. Sev-
eral studies have shown the superiority of 3D TEE in the
evaluation of the MV normal and pathologic morphology,
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quantification of mitral regurgitation or stenosis [7–12]
and comprehensive evaluation of MV prolapse before
surgery [13, 14].
However, 3D echocardiography has specific limitations.
It requires training for both image acquisition and ana-
lysis. The image post-processing is time consuming, with
low inter- and intra-observer reproducibility of manual
measurements in many cases. The latter has created the
need to develop automatic software able to both reduce
image analysis time and increase reproducibility. Available
computational geometric and biomechanical software re-
quire the user’s identification of MV structures as well as
manual tracing, being time consuming and limiting repro-
ducibility [15–18].
New automatic software for MV analysis as the one
evaluated in the present study are promising for its use
in clinical practice. Reproducibility is key point for the
quantitative evaluation of non-invasive imaging techniques.
Moreover, they constitute one of the main limitations of
conventional echocardiography affecting patient’s diagnosis
and management. For this reason new technological devel-
opments, need to prove their efficacy with higher reprodu-
cibility before they can be used in clinical practice
replacing the available conventional methods. Accordingly,
the aim of our study was to evaluate inter- and intra-
observer reproducibility of a novel full-automated software
in the evaluation of MV anatomy compared to routine
clinical manual 3D assessment.
Methods
Patients
A total of 331 patients referred to the Cardiac Imaging Unit
for TEE from January to September 2013 were initially
screened for this study. Of the total screened population,
88 patients underwent TEE using an echocardiographic
system not compatible with the automated software ana-
lysis. Of the remaining 243 patients with a TEE preformed
with an iE33 ultrasound imaging system (Philips Medical
System, Andover, MA), 80 patients had a 3D zoom of the
mitral valve (MV). Of these 80 patients, 19 patients were
excluded because they had a mitral prosthesis implant. Of
the remaining 61 patients, 25 patients were excluded be-
cause of (i) poor-quality 3D images with stitching artefacts
due to arrhythmia, (ii) a frame rate below 7 volumes per
second or (iii) poor image quality for the software auto-
matic quantification (i.e., incomplete imaging of the mi-
tral annulus). Thus, final study population retrospectively
included a total of 36 patients with 15 patients in sinus
rhythm, 16 patients in atrial fibrillation and 5 with
PM-dependent rhythm.
Echocardiography
All patients underwent TEE according to the European
Association of Cardiovascular Imaging Guidelines [19]
using a multiplane transoesophageal 7X-2 t matrix probe.
Both clinical TEE examination and 3D MV images were
undertaken according to the performing physician. 3D
MV images were obtained using 3D zoom modalities
acquired over one cardiac cycle with frame rate ranging
from 7 to 34 volumes per second except for two patients
for which the images were obtained over 4 cardiac cycles.
Images were digitally stored and transferred to a worksta-
tion for offline analysis.
3D data analysis
In each subject the highest quality 3D images were selected
for analysis. Same volume dataset and frame were used for
both manual and software analysis, which included the fol-
lowing parameters: intercommissural distance, the area of
mitral annulus and the leaflets length. After importing the
images into the software (eSie Valves, Autovalve prototype
version 1.22, Siemens Medical Solutions, USA) the MV is
shown in different views (Fig. 1). It is worth noting here
that currently Philips and Siemens are the echocardio-
graphic system compatible with the automated software
analysis. Following manual selection of the appropriate
frame, automatic recognition of the MV is performed by
the detection of 7 landmarks and more than 400 add-
itional mitral annulus landmarks obtained in 50 different
planes [15] that can be edited as needed. A MV model is
computed based on these landmarks and different MV pa-
rameters are obtained. Manual measurements of the MV
were performed using QLab 11; Philips Medical System.
Multiplanar reconstruction of the 3D dataset was per-
formed. Orthogonal axis was aligned obtaining 3 different
MV planes: 4 chambers, 3 chambers and short axis view.
The MV parameters were assessed at the time of maximal
valve opening (mid diastolic frame). Both planimetry of
the MV annulus and intercommissural diameter were
assessed in the short axis view. Subsequently the leaflets
length was measured in mid to late diastolic time in the 3
chambers view (Fig. 2).
Statistical analysis
All quantitative data obtained by manual and software
assessments were presented as mean ± standard deviation
(SD). Comparison between both techniques was performed
using a paired Student’s t-test. Differences were considered
significant at p <0.05, and linear regression analysis was
used to test correlation of variables. To test inter-observer
variability between both methods, all images were analysed
by 2 cardiologists that independently reviewed the 3D
images and made both the manual measurements and
used the automated software. One observer repeated
the measurements in 15 randomly selected cases at 2
different time points to assess intra-observer variability.
The inter-observer and intra-observer variability were
analysed using the Bland-Altman method [20]. Inter-observer
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and intra-observer agreements for qualitative analysis
score by 3D Echo manual and software assessments
were calculated using intraclass correlation coefficients
and classified as excellent with value of 0.93–1.0, very
good 0.81–0.92, good 0.41–0.60, and poor < 0.4 classified
as low if ICC < 0.4, fair if ICC 0.4–0.75 and excellent if
ICC > 0.75 [21]. Statistical analyses were performed using
SPSS version 22.0 (SPSS, Inc., Chicago, Illinois) and Stata
SE version12.0 (StataCorp, Texas).
Results
Clinical characteristics of the study cohort are shown in
Table 1. 6 (17 %) patients had normal mitral valve, 9
(25 %) mitral regurgitation due to isolated MV prolapse
or associated to chordae tendinae rupture, 9 (25 %) de-
generative MV disease, 8 (22 %) rheumatic valve disease, 3
(8 %) functional mitral regurgitation and 1 (3 %) patient
had MV perforation secondary to endocarditis.
No significant differences were noted between all pa-
rameters but intercommissural distance (Table 2, Fig. 3).
Manual assessment of intercommissural diameter was sig-
nificantly correlated with intercommissural diameter by
the automated software (r = 0.84, p < 0.01; Fig. 4), but man-
ual calculation resulted in higher measurements compared
to those measured using automated software (mean differ-
ence -2.93 ± 2.41; p < 0.01) (Fig. 5). Area of mitral annulus
and anterior valve length assessed manually and with the
automated software show strong correlations (r = 0.94 and
r = 0.83 respectively, all p < 0.01) and good levels of agree-
ment (Figs. 4 and 5). Correlation of posterior leaflet length
by manual assessment and automated software was less
strong (r = 0.67, p < 0.01) but did not show significant
differences regardless of the method used (mean differ-
ence −0.15 ± 1.9, p 0.65) (Figs. 4 and 5).
3D automated Software measurements showed a better
interobserver agreement in all the imaging parameters.
Fig. 1 Representative image of the automatic software analysis of the mitral valve. Different views of the mitral valve are shown with the
different structures automatically detected and the final 3D modelling of the mitral valve
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Intraclass correlation coefficient for 3D manual and 3D
automated Software measurements respectively was 0.76
(95 % CI 0.58 to 0.87) and 0.99 (95 % CI 0.99 to 0.99) for
intercommissural distance; 0.85 (95 % CI 0.73 to 0.92) and
0.95 (95 % CI 0.91 to 0.97) for area of mitral annulus;
0.734 (95 % CI 0.53 to 0.85) and 0.963 (95 % CI 0.92 to
0.98) for anterior leaflet length; 0.838 (95 % CI 0.705 to
0.941) and 0.936 (95 % CI 0.879 to 0.967) for posterior
leaflet length.
Intraobserver variability showed a superior agreement
with 3D automated Software for all measurements but
posterior leaflet length. Intra-class correlation coefficient
was: intercommissural distance, 0.938 [95 % confidence
interval (CI) 0.827 to 0.979] for 3D manual assessment
and 0.999 (95 % CI 0.998 to 1.0) for the 3D automated
Software; area of mitral annulus, 0.969 (95 % CI 0.991 to
0.990) for 3D manual assessment and 0.992 (95 % CI
0.975 to 0.997) for the 3D automated software; anterior
leaflet length, 0.882 (95 % CI 0.685 to 0.959) for 3D
manual assessment and 0.984 (95 % CI 0.954 to 0.995)
for the 3D automated Software; posterior leaflet length,
0.946 (95 % CI 0.846 to 0.981) for 3D manual assess-
ment and 0.937 (95 % CI 0.824 to 0.978) for the 3D au-
tomated Software.
Discussion
The main findings of the present study are that: 1) the 3D
automated software correctly evaluates MV morphology
Fig. 2 Representative image of a multiplanar reconstruction of the 3D dataset as obtained by manual measurements of the MV
Table 1 Baseline characteristics of the study population
n (%)
Age (years) 72 ± 12,4
Gender, male n (%) 17 (47 %)
Hypertension, n (%) 28 (78 %)
Hypercholesterolemia, n (%) 11 (31 %)
Diabetes mellitus, n (%) 11 (31 %)
Smoking, n (%) 9 (25 %)
Sinus rhythm, n (%) 15 (42 %)
Atrial fibrillation, n (%) 16 (44 %)
Ejection fraction (EF) < 45 %. 4 (11 %)
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and dimensions; 2) the MV evaluation by the automated
software strongly correlates with the operator´s manual
analysis; 3) the software analysis is reliable, reproducible
and operator-independent.
MV disease prevalence is high, with a growing number
of patients requiring intervention. The increasing num-
ber and complexity of both surgical and percutaneous
treatments, with clear anatomic requirements (edge-to-
edge MV repair technique using MitraClip) demands
imaging techniques to be more precise, accurate and re-
producible for both patient selection and intraprocedural
control [22]. Although 3D TEE offers a better diagnostic
accuracy compared to 2D TEE, it has not yet become
widespread in the clinical routine. Commercially available
3D echocardiography analysis packages allow only for a
limited number of quantitative measures to be performed
offline. Custom software algorithms that allow interactive
visualization and automated quantification have been de-
veloped, but these techniques are time consuming, and
labour intensive with poor reproducibility [15]. For all the
above reasons, the increased interest in a precise morpho-
logical and functional evaluation of the MV has reinforced
the need to introduce into clinical practice 3D models able
to generate a detailed morphological reconstruction as






Intercommissural diameter (mm) 28.1 ± 4.4 25.16 ± 4.1 0.00
Area of mitral annulus (mm2) 802.5 ± 190.8 814.7 ± 194.4 0.28
Anterior leaflet length (mm) 22.8 ± 2.2 22.7 ± 2.9 0.56
Posterior leaflet length (mm) 12.7 ± 2.2 12.6 ± 2.5 0.65
*Automated software versus manual assessment paired Student t-test
Fig. 3 Box plots with the cumulative data of the four mitral valve anatomical parameters as assessed by the automatic software versus manual evaluation
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well as sophisticated quantification of the complex MV
structure and dynamics throughout the cardiac cycle with
high precision [23].
To the best of our knowledge, no clinical studies have
assessed the feasibility and reproducibility of quantifica-
tion of the MV complex using the automated software
eSie Valves as shown in the present study. Our results
show no significant differences between mean values ob-
tained with the software and 3D manual assessment ex-
cept for the intercommissural distance (Table 2, Fig. 3).
In this parameter, even though Pearson correlation coef-
ficient was high (Fig. 4), the software systematically
showed lower results (Fig. 5). This is easily explained by
the different methodology used in both methods: commis-
sures are detected by the software in the 3D space and
then the Euclidian distance between them is calculated.
However, in the 3D manual analysis, the commissures are
identified in 2D images after multiplanar reconstruction,
in the short axis view and a straight line is traced between
them. Moreover, commissures are not exact anatomical
landmarks, and represent the continuity between the
anterior and posterior leaflet extending over some milli-
metres. Additionally, intercommissural distance is not the
main and standard parameter to guide prosthesis size
and thus it should not impact the use of the automated
software for percutaneous mitral prosthesis implantation
in the future. A good correlation was found between the
rest of the measurements performed with the software
and manual 3D analysis (Fig. 4) without significant bias
(Fig. 5). The lowest correlation was seen for the posterior
mitral leaflet length but no significant differences in mean
values were seen whatsoever. This may be due to the fact
that posterior leaflet length was manually measured at P2,
while the software computed maximal posterior leaflet
length, which in some cases may be a little different.
However, grade of agreement did not show significant
bias either. Additional MV parameters obtained with
the software were not included in the analysis. This was
decided due to inherent limitations of the 3D manual
assessment that would have limited the evaluation of
software´s accuracy. Since there is no clear gold standard
for most of MV parameters obtained, clinical studies are
needed in order to prove their accuracy and usefulness.
Despite it was not specifically addressed, the automatic
software reduced of at least half the time for analysis when
compared to manual evaluation further underlying the
Fig. 4 Correlations between intercommissural diameter (a), area of mitral annulus (b), anterior leaflet length (c) and posterior leaflet length
(d) determined by automated software and manual assessment
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clinical usefulness of the software. However, further stud-
ies are needed to specifically quantify the time-saving by
the automatic software.
Regarding inter and intraobserver reproducibility, our
work confirms superiority of the automated software over
3D manual assessment. These findings are in agreement
with a previous report that tested reproducibility of the
same software in 18 patients undergoing coronary bypass
surgery [23].
The increasing number of interventional procedures
demands non-invasive imaging techniques to be more
reproducible for its use in clinical practice. Those not
able to fulfil these requirements will be left behind in the
near future where new surgical and interventional devices
develop to treat different forms of MV disease. In this re-
gard, the future of 3D echocardiography requires not only
to generate superb image quality with high temporal and
spatial resolution but also to offer reproducible quantifica-
tion and to be operator independent. For these reason re-
sults of the present study are of paramount importance,
highlighting the ability of technical developments, as the
software evaluated, to respond to real needs of echocardi-
ography. Reproducibility results obtained in two separate
studies further reinforce its strengths and support its
applicability in every day clinical practice.
Limitations
First, we did not compare our measurements performed
manually and by the software with pathologic findings
during cardiac surgery in absence of a gold standard able
to define a correct validation of the measurements made.
Second, in 41 % of patients it was not possible to perform
the analysis retrospectively. This translates the importance
of high quality 3D images and the need to include the en-
tire MV annulus in the acquired volume. Third, the study
patients’ cohort is clearly inhomogeneous as it spans from
normal mitral valve to different aetiologies of mitral valve
disease. However, it should be pointed out that in this
study we specifically assessed the reproducibility of the au-
tomated software analysis compared to manual evaluation
of the mitral valve apparatus independently from the pres-
ence or absence of any pathology of the valve. Finally, the
automated software analysis includes by default of a num-
ber of other parameters (like mitral orifice area, tenting
volume, tenting height, annulus non planarity angle scalar
etc. etc.) that were not reported in this study. This is so
Fig. 5 Bland-Altman scatterplot demonstrating the agreement in the measurement of MV intercommissural diameter (a), area of mitral annulus
(b), anterior leaflet length (c) and posterior leaflet length (d) measured by automated software and manual assessment. Intercommissural diameter
measured using automated software was underestimated when compared to manual evaluation. The solid horizontal line in each plot represents the
mean systematic difference (bias) between the two methods, whereas the dashed lines indicate the limits of agreement (95 % confidence
interval of differences)
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because these additional parameters are not part of a
standard manual evaluation and thus they were not
used for the comparison.
Conclusion
The new eSieValves software has proved to be reprodu-
cible in MV anatomic evaluation. From high quality 3D
TEE images, it allows the possibility of correctly analys-
ing several MV parameters in one frame and over the
cardiac cycle, opening new possibilities in the under-
standing of physiology and pathology of this complex
structure. These features may improve not only surgical
and interventional procedures planning but also diagno-
sis and prognosis stratification in MV disease patients.
Further clinical studies are needed to define clinical ap-
plication of the MV parameters obtained.
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